MedPath

Ritedose Pharmaceuticals, LLC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

11

FDA:11

Drug Approvals

Albuterol Sulfate Inhalation Solution, 0.5%

Approval Date
Mar 24, 2025
FDA

IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE

Approval Date
Dec 20, 2023
FDA

Albuterol Sulfate

Approval Date
Dec 20, 2023
FDA

Arformoterol Tartrate Inhalation Solution

Approval Date
Dec 20, 2023
FDA

Albuterol Sulfate Inhalation Solution

Approval Date
Dec 20, 2023
FDA

Ipratropium Bromide

Approval Date
Dec 20, 2023
FDA

Levalbuterol

Approval Date
Dec 20, 2023
FDA

Cromolyn Sodium Oral Solution (Concentrate)

Approval Date
Dec 20, 2023
FDA

Cromolyn Sodium Inhalation Solution

Approval Date
Aug 9, 2023
FDA

Budesonide Inhalation Suspension

Approval Date
Dec 16, 2022
FDA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.